Ganesha, the US fda has nothing to do with approving the
Ganesha, the US fda has nothing to do with approving the Brazilian protocol. It's all up to Anvisa. Now, when the trial progresses and he hit interim, (120 or 40%), and the results are really exceptional, ( I am in this camp), the US fda can use it toward a US approval for EUA only, not approval. I believe this to be true but someone can correct me if I'm wrong -
GLTU and relax over the weekend as our stress for the weekend is subsiding some what and that goes for all here on the board and we all need a breather from this crazy trading pattern that has us mired in mud with what we saw on L-2 this week
HCIT
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Republic Digital Acquisition Company Enhances Trading Opportunities Republic Digital Acquisition Company (NASDAQ: RDAGU) has recently made a significant announcement regarding the trading of its securities. Starting from June 23, 2025, shareholders will have the opportunity to trade their Class A ordinary shares and warrants separately. This strategic move allows for...
Continue Reading
When you're whipping up headlines with a margin expansion like Webull's this quarter, it demands a second look. Buckle up as we dive into the nuts and bolts of what made this past quarter tick for NASDAQ:BULL. Record-Breaking Quarter: A Rising Tide On the surface, Webull came out swinging with a record revenue of $198.8 million, up a sky-high 51% from the previous year....
Continue Reading
Curaleaf Introduces Automatic Securities Disposition Plan Curaleaf Holdings, Inc. (TSX: CURA /OTCQX: CURLF) has officially unveiled its new automatic securities disposition plan (ASDP), effective from the end of September 2025. This strategic initiative is aimed at providing a structured method for the disposal of shares owned by Mr. Joseph F. Lusardi, the Company's...
Continue Reading
Overview of Recent Inducement Grants TELA Bio, Inc. (NASDAQ: TELA), a leading name in medical technology, has made an exciting announcement concerning its recent induction of new talent into the company. Approved by the Compensation Committee of the Board of Directors, TELA Bio has granted restricted stock units covering 3,600 shares to three newly-hired employees. The...
Continue Reading
Excelling Large-Cap Stocks: What You Need to Know In the dynamic world of investments, staying updated on stock performance is vital. Recently, several large-cap stocks have significantly increased in value. Let’s dive into some of the top performers and explore their news and developments. Xpeng: A Leading Electric Vehicle Player Xpeng Inc. (NYSE: XPEV) has been making...
Continue Reading
